Effects of exenatide therapy on insulin resistance in the skeletal muscles of high-fat diet and low-dose streptozotocin-induced diabetic rats

Skeletal Muscle Mitochondrial Capacity and Insulin Resistance in Type 2 Diabetes

(2011) Sudip Bajpeyi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Obesity, insulin resistance and free fatty acids

(2011) Guenther Boden   Current Opinion in Endocrinology Diabetes and Obesity

Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities

(2009) William I. Sivitz et al.   ANTIOXIDANTS & REDOX SIGNALING

Application of Isotopic Techniques Using Constant Specific Activity or Enrichment to the Study of Carbohydrate Metabolism

(2009) A. Vella et al.   DIABETES

Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes

(2009) R. A. DeFronzo et al.   DIABETES CARE

Endogenous Glucagon-Like Peptide-1 Slows Gastric Emptying in Healthy Subjects, Attenuating Postprandial Glycemia

(2009) Adam M. Deane et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Increased carnitine palmitoyl transferase 1 expression and decreased sterol regulatory element–binding protein 1c expression are associated with reduced intramuscular triglyceride accumulation after insulin therapy in high-fat–diet and streptozotocin-induced diabetic rats

(2009) Yan Bi et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Exenatide: clinical aspects of the first incretin-mimetic for the treatment of type 2 diabetes mellitus

(2008) Estela Wajcberg et al.   EXPERT OPINION ON PHARMACOTHERAPY